Beyondspring Stock News

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-shortened week. Shares of companies with a COVID portfolio, including a vaccine, a treatment or both, reacted with strong moves to the upside in the truncated session on Friday. Takeda Pharmaceutical Company Limited (NYSE: TAK ) and Aadi Bioscience, Inc. (NASDAQ: AADI ) received Food and Drug Administration nod for their Livtencity and Fyarro, respectively. Here are the catalysts that could impact trading in the upcoming week: Conferences The Evercore ISI 4th Annual HealthCONx Virtual Conference: Nov. 30-Dec. 2 Piper Sandler 33rd Annual Virtual Healthcare Conference: Nov. 29-Dec. 2 American Epilepsy Society, or AES, 2021 Annual Meeting: Dec. 3-7, in Full story available on Benzinga.com

BeyondSpring Inc. (NASDAQ:BYSI)s share price gapped up before the market opened on Friday . The stock had previously closed at $13.28, but opened at $14.05. BeyondSpring shares last traded at $14.25, with a volume of 3,713 shares. Several research firms have recently commented on BYSI. Robert W. Baird began coverage on BeyondSpring in a research []

Shares of BeyondSpring Inc. (NASDAQ:BYSI) have been assigned a consensus recommendation of Buy from the six analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokerages that have []

BeyondSpring Inc. (NASDAQ:BYSI) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 4.90% to the previous days close as strong demand from buyers drove the stock to $13.28. Actively observing the price movement in the last trading, the stock closed the session at $12.66, falling within a range of $12.10 and BeyondSpring Inc. (NASDAQ: BYSI) Jumps 4.90%: Is This A Sign Of Things To Come? Read More »

NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics,

NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced that management will participate in a Fireside Chat and host one-on-one investor meetings during the 4 th Annual Evercore ISI HealthCONx Conference, taking place November 30-December 2, 2021. Details for the Fireside Chat can be found below:

NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, to

BeyondSpring (NASDAQ:BYSI) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report issued on Monday, Zacks.com reports. According to Zacks, BeyondSpring Inc. is a clinical stage biopharmaceutical company. It focused on the development of cancer therapies. The Companys lead product consists of into a Phase 3 clinical trial []

Brokerages forecast that BeyondSpring Inc. (NASDAQ:BYSI) will report ($0.56) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for BeyondSprings earnings. The lowest EPS estimate is ($0.69) and the highest is ($0.48). BeyondSpring reported earnings of ($0.48) per share during the same quarter last year, which would []

Rothschild Investment Corp IL bought a new stake in BeyondSpring Inc. (NASDAQ:BYSI) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,500 shares of the companys stock, valued at approximately $197,000. Several other institutional investors have also recently bought and []

BeyondSpring Inc. (NASDAQ:BYSI) price on Friday, November 19, fall -0.53% below its previous days close as a downside momentum from buyers pushed the stocks value to $13.25. A look at the stocks price movement, the close in the last trading session was $13.32, moving within a range at $13.03 and $13.77. The beta value (5-Year BeyondSpring Inc. (BYSI) Outlook: Looking Back For Insights Read More »

Geode Capital Management LLC increased its position in BeyondSpring Inc. (NASDAQ:BYSI) by 14.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 198,094 shares of the companys stock after buying an additional 25,741 shares during the quarter. Geode Capital Management LLC owned 0.51% []

Related Stocks: BYSI , NXE , AMRS , CG , MO , CCJ ,

Today, we look back in on a small oncology company called BeyondSpring for the first time since early this year. The stock quadrupled in August on good trial results but has fallen back 40% since then

JPMorgan Chase & Co. decreased its stake in BeyondSpring Inc. (NASDAQ:BYSI) by 65.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,141 shares of the company’s stock after selling 36,513 shares during the quarter. JPMorgan Chase & Co.’s holdings […]